Impact of COVID-19 infection in the occurrence of avascular necrosis of head of femur: a case series in a tertiary care hospital in Central Gujarat

Authors

  • Fatimakhatun Z. Memon Narendra Modi Medical College, Ahmedabad, Gujarat, India
  • Gurusharan Dumra Department of Pharmacology, Narendra Modi Medical College, Ahmedabad, Gujarat, India
  • Dhruvi Joshi Narendra Modi Medical College, Ahmedabad, Gujarat, India
  • Vivek Vishalbhai Mehta Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
  • Nisarg Shah Department of Orthopaedics, Narendra Modi Medical College, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20250640

Keywords:

Avascular necrosis, COVID-19, Hypercoagulability, Steroids

Abstract

Avascular necrosis (AVN) is a degenerative bone condition characterized by the death of bone tissue due to reduced blood supply. Recent studies suggest an increased incidence of AVN in post-COVID-19. This may be linked to the virus-induced hypercoagulable state and corticosteroid treatment. However, there is a dearth of evidence to substantiate this association. Therefore, this case series aims to elucidate the potential relationship between COVID-19 infection and AVN. This case series included 11 male patients (ages 25-49) diagnosed with AVN following COVID-19 infection between January 2022 and August 2023. The results indicated a higher incidence of AVN in younger males (mean age: 35 years, range: 25-49), highlighting potential age- and gender-related risks of AVN among the post-COVID-19. Despite excluding patients with pre-COVID steroid use, AVN occurred in those with steroid exposure during COVID-19 treatment and even in home-isolated cases without steroid use. Additionally, the study reported a higher side of the normal range of D-dimer and CRP levels, suggesting hypercoagulability and inflammation may have accelerated AVN progression, with concurrent alcohol and tobacco use potentially increasing risk.

Metrics

Metrics Loading ...

References

Agarwala SR, Vijayvargiya M, Pandey P. Avascular necrosis as a part of “long COVID-19.” BMJ Case Rep. 2021;14(7):e242101. DOI: https://doi.org/10.1136/bcr-2021-242101

Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. Diabetes Metab Syndr. 2021;15(4):102146. DOI: https://doi.org/10.1016/j.dsx.2021.05.019

Parums D V. Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19. Available at: https://covid19.who.int. Accessed on 12 January 2025.

Molaverdi G, Kamal Z, Safavi M, Shafiee A, Mozhgani SH, Ghobadi MZ, Goudarzvand M. Neurological complications after COVID-19: A narrative review. eNeurologicalSci. Elsevier. 2023;33:100485. DOI: https://doi.org/10.1016/j.ensci.2023.100485

Zacharias H, Dubey S, Koduri G, D’Cruz D. Rheumatological complications of COVID-19. Autoimmun Rev. Elsevier. 2021;20(9):102883. DOI: https://doi.org/10.1016/j.autrev.2021.102883

Matthews AH, Davis DD, Fish MJ, Stitson D. Avascular Necrosis. StatPearls. StatPearls Publishing. 2022.

Covid: Hip Surgeries See Rise Among COVID Infected | Hyderabad News-Times of India. Available at: https://timesofindia.indiatimes.com/city/hyderabad/hip-surgeries-see-rise-among-covid-infected/articleshow/92400402.cms. Accessed on 16 September 2024

Shetty GM. Double Trouble-COVID-19 and the Widespread Use of Corticosteroids: Are We Staring at an Osteonecrosis Epidemic? Ind J Orthopaed. 2022;56(2):226-36. DOI: https://doi.org/10.1007/s43465-021-00546-8

Shah KN, Racine J, Jones LC, Aaron RK. Pathophysiology and risk factors for osteonecrosis. Curr Rev Musculoskelet Med. 2015;8(3):201-9. DOI: https://doi.org/10.1007/s12178-015-9277-8

Romano GM, Cafiero T, Frangiosa A, Robertis E De. Corticosteroids in patients with COVID-19: Use and misuse. Minerva Anestesiol. Edizioni Minerva Medica. 2021;87(9):1042-8. DOI: https://doi.org/10.23736/S0375-9393.21.15625-1

Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev. Brit Editorial Society of Bone Joint Surg. 2019;4(3):85-97. DOI: https://doi.org/10.1302/2058-5241.4.180036

Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the Hip: A Primer. Perm J Kaiser Permanente. 2019;23(1):18-100. DOI: https://doi.org/10.7812/TPP/18-100

Migliorini F, Maffulli N, Shukla T, D’Ambrosi R, Singla M, Vaish A, et al. The pandemic is gone but its consequences are here to stay: avascular necrosis following corticosteroids administration for severe COVID-19. J Orthop Surg Res. 2024;19(1):1-11. DOI: https://doi.org/10.1186/s13018-024-04556-8

Lamb JN, Holton C, O’Connor P, Giannoudis P V. Avascular necrosis of the hip. Brit Med J. 2019;365:l2178. DOI: https://doi.org/10.1136/bmj.l2178

Lohiya A Jr, Dhaniwala N, Dudhekar U, Goyal S, Patel SK. A Comprehensive Review of Treatment Strategies for Early Avascular Necrosis. Cureus. 2023;15(12):e50510. DOI: https://doi.org/10.7759/cureus.50510

Downloads

Published

2025-02-28

How to Cite

Memon, F. Z., Dumra, G., Joshi, D., Mehta, V. V., & Shah, N. (2025). Impact of COVID-19 infection in the occurrence of avascular necrosis of head of femur: a case series in a tertiary care hospital in Central Gujarat. International Journal Of Community Medicine And Public Health, 12(3), 1473–1478. https://doi.org/10.18203/2394-6040.ijcmph20250640

Issue

Section

Case Series